Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Vitamin K antagonists. Ready to be replaced?

Steffel J, Luscher TF.

Hamostaseologie. 2012;32(4):249-57. doi: 10.5482/ha-12050008. Epub 2012 Sep 7. Review.

PMID:
22955200
2.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
3.

Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants?

Cohen H, Machin SJ.

Lupus. 2010 Apr;19(4):486-91. doi: 10.1177/0961203310361355. Review.

PMID:
20353992
4.

New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Scaglione F.

Clin Pharmacokinet. 2013 Feb;52(2):69-82. doi: 10.1007/s40262-012-0030-9. Review.

PMID:
23292752
5.

Will warfarin ever be replaced?

Ruff CT, Braunwald E.

J Cardiovasc Pharmacol Ther. 2010 Sep;15(3):210-9. doi: 10.1177/1074248410366448. Epub 2010 May 18. Review.

PMID:
20484119
6.

Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?

Dzeshka MS, Lip GY.

Trends Cardiovasc Med. 2015 May;25(4):315-36. doi: 10.1016/j.tcm.2014.10.017. Epub 2014 Oct 30. Review.

PMID:
25440108
7.

New antithrombotics for atrial fibrillation.

Bereznicki LR, Peterson GM.

Cardiovasc Ther. 2010 Oct;28(5):278-86. doi: 10.1111/j.1755-5922.2010.00209.x. Epub 2010 Jul 14. Review.

PMID:
20645985
8.

New oral anticoagulants in atrial fibrillation.

Turpie AG.

Eur Heart J. 2008 Jan;29(2):155-65. Epub 2007 Dec 19. Review.

PMID:
18096568
9.

Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.

Schneeweiss S, Gagne JJ, Patrick AR, Choudhry NK, Avorn J.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):480-6. doi: 10.1161/CIRCOUTCOMES.112.965988. Epub 2012 Jul 10.

10.

Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.

Steffel J, Lüscher TF.

J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):616-23. doi: 10.2459/JCM.0b013e32832edac0. Review.

PMID:
19561526
11.

Changing anticoagulant paradigms for atrial fibrillation: dabigatran, apixaban and rivaroxaban.

Giorgi MA, Cohen Arazi H, Gonzalez CD, Di Girolamo G.

Expert Opin Pharmacother. 2011 Mar;12(4):567-77. doi: 10.1517/14656566.2011.528754. Epub 2011 Jan 22. Review.

PMID:
21254865
12.

[When to replace the vitamin K antagonists by new anticoagulants?].

Fournet M, Daubert JC.

Rev Prat. 2013 Sep;63(7):970-5. French.

PMID:
24167900
13.

Newer anticoagulants in cardiovascular disease: a systematic review of the literature.

Maan A, Padmanabhan R, Shaikh AY, Mansour M, Ruskin JN, Heist EK.

Cardiol Rev. 2012 Sep-Oct;20(5):209-21. doi: 10.1097/CRD.0b013e3182503e2d. Review.

PMID:
22370770
14.

[Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].

Gorzelak P, Zyzak S, Krewko Ł, Mozdzan M, Broncel M.

Pol Merkur Lekarski. 2014 May;36(215):302-6. Polish.

PMID:
24964505
15.

Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Becattini C, Vedovati MC, Agnelli G.

Thromb Res. 2012 Mar;129(3):392-400. doi: 10.1016/j.thromres.2011.12.014. Epub 2012 Jan 20. Review.

PMID:
22264937
16.

Emerging anticoagulant therapies for atrial fibrillation: new options, new challenges.

Mangiafico RA, Mangiafico M.

Curr Med Chem. 2012;19(27):4688-98. Review.

PMID:
22830344
17.

Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.

Schirmer SH, Baumhäkel M, Neuberger HR, Hohnloser SH, van Gelder IC, Lip GY, Böhm M.

J Am Coll Cardiol. 2010 Dec 14;56(25):2067-76. doi: 10.1016/j.jacc.2010.09.017. Review.

18.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
19.

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.

Lip GY, Rasmussen LH, Olsson SB, Jensen EC, Persson AL, Eriksson U, Wåhlander KF; Steering Committee.

Eur Heart J. 2009 Dec;30(23):2897-907. doi: 10.1093/eurheartj/ehp318. Epub 2009 Aug 18.

20.

Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism.

Steffel J, Braunwald E.

Eur Heart J. 2011 Aug;32(16):1968-76, 1976a. doi: 10.1093/eurheartj/ehr052. Epub 2011 Mar 18. Review.

PMID:
21421599

Supplemental Content

Support Center